UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000012576
Receipt number R000014711
Scientific Title Effect of Rosuvastatin and eicosapentaenoic acid on neoatherosclerosis: The LINK-IT trial
Date of disclosure of the study information 2013/12/14
Last modified on 2020/01/09 09:15:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of Rosuvastatin and eicosapentaenoic acid on neoatherosclerosis: The LINK-IT trial

Acronym

Effect of Rosuvastatin and eicosapentaenoic acid on neoatherosclerosis: The LINK-IT trial

Scientific Title

Effect of Rosuvastatin and eicosapentaenoic acid on neoatherosclerosis: The LINK-IT trial

Scientific Title:Acronym

Effect of Rosuvastatin and eicosapentaenoic acid on neoatherosclerosis: The LINK-IT trial

Region

Japan


Condition

Condition

coronary artery disease patient with in-stent neoatherosclerosis

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aim to evaluate whether intensive lipid lowering therapy may improve the clinical outcomes in coronary artery disease patients with in-stent neoatherosclerosis, in comparison with standard therapy.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Change in lipid index analyzed by optical coherence tomography

Key secondary outcomes

Ischemic driven TLR, MACE(death, myocardial infarction, TLR), and stent thrombosis, other OCT parameters


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

Active

Stratification

NO

Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Intensive lipid lowering therapy
start with EPA and Rosuvastatin 10 mg/day and up to 20 mg/day

Interventions/Control_2

Standard lipid lowering therapy
start with only Rosuvastatin 2.5 mg/day and up to 20 mg/day

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients meeting all of the following conditions will be included:
AN detected by OCT >1 year after stent implantation
(Include any type of stent [BMS, 1st generation DES, and 2nd generation DES])
between 20 and 85 years old
written consent for participation in the study

Key exclusion criteria

Patients meeting one of the following conditions will be excluded:
1) severe liver dysfunction
2) renal dysfunction (<Cre 2.0mg/dL)
3) severe heart failure (NYHA/New York Heart Association stage III or severer)
4) malignancies or other diseases with poor prognosis
5) pregnant, lactating, and possibly pregnant women and those planning to become pregnant
6) past medical history of hypersensitivity to investigational drugs
7) judged as ineligible by clinical investigators

Target sample size

50


Research contact person

Name of lead principal investigator

1st name Hiromasa
Middle name
Last name Otake

Organization

Kobe University Graduate School of Medicine

Division name

Division of Cardiovascular Medicine

Zip code

6500017

Address

7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan

TEL

078-382-5111

Email

hotake@med.kobe-u.ac.jp


Public contact

Name of contact person

1st name Hiromasa
Middle name
Last name Otake

Organization

Kobe University Graduate School of Medicine

Division name

Division of Cardiovascular Medicine

Zip code

6500017

Address

7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan

TEL

078-382-5111

Homepage URL


Email

hotake@med.kobe-u.ac.jp


Sponsor or person

Institute

Division of Cardiovascular Medicine, Kobe University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Division of Cardiovascular Medicine, Kobe University Graduate School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

IRB of Kobe University Hospital

Address

7-5-2 Kusunoki-cho Chuo-ku, Kobe City

Tel

078-382-6669

Email

chiken@med.kobe-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2013 Year 12 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 11 Month 10 Day

Date of IRB

2014 Year 01 Month 15 Day

Anticipated trial start date

2014 Year 01 Month 29 Day

Last follow-up date

2017 Year 06 Month 02 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2013 Year 12 Month 14 Day

Last modified on

2020 Year 01 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014711


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name